Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Assets Average (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Assets Average for 13 consecutive years, with $305.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 15.86% year-over-year to $305.1 million, compared with a TTM value of $305.1 million through Dec 2025, down 15.86%, and an annual FY2025 reading of $328.7 million, down 21.64% over the prior year.
  • Assets Average was $305.1 million for Q4 2025 at Enanta Pharmaceuticals, up from $290.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $478.7 million in Q3 2023 and bottomed at $290.9 million in Q3 2025.
  • Average Assets Average over 5 years is $393.6 million, with a median of $401.1 million recorded in 2022.
  • The sharpest move saw Assets Average grew 25.88% in 2023, then fell 24.98% in 2025.
  • Year by year, Assets Average stood at $439.7 million in 2021, then dropped by 17.79% to $361.5 million in 2022, then increased by 23.21% to $445.4 million in 2023, then fell by 18.58% to $362.6 million in 2024, then decreased by 15.86% to $305.1 million in 2025.
  • Business Quant data shows Assets Average for ENTA at $305.1 million in Q4 2025, $290.9 million in Q3 2025, and $312.0 million in Q2 2025.